BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28656062)

  • 21. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.
    Shai A; Dankort D; Juan J; Green S; McMahon M
    Cancer Res; 2015 Aug; 75(15):3167-80. PubMed ID: 26001956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
    Stefan E; Bister K
    Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Toll-like Receptor 4 Overexpression in Papillary Thyroid Cancer by MAPK/ERK-Induced ETS1 Transcriptional Activity.
    Peyret V; Nazar M; Martín M; Quintar AA; Fernandez EA; Geysels RC; Fuziwara CS; Montesinos MM; Maldonado CA; Santisteban P; Kimura ET; Pellizas CG; Nicola JP; Masini-Repiso AM
    Mol Cancer Res; 2018 May; 16(5):833-845. PubMed ID: 29523762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf
    Tao Y; Kang B; Petkovich DA; Bhandari YR; In J; Stein-O'Brien G; Kong X; Xie W; Zachos N; Maegawa S; Vaidya H; Brown S; Chiu Yen RW; Shao X; Thakor J; Lu Z; Cai Y; Zhang Y; Mallona I; Peinado MA; Zahnow CA; Ahuja N; Fertig E; Issa JP; Baylin SB; Easwaran H
    Cancer Cell; 2019 Feb; 35(2):315-328.e6. PubMed ID: 30753828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
    Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
    Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.
    Kuser-Abali G; Alptekin A; Cinar B
    Epigenetics; 2014 Apr; 9(4):634-43. PubMed ID: 24499724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
    J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc.
    Lin CH; Lin C; Tanaka H; Fero ML; Eisenman RN
    PLoS One; 2009 Nov; 4(11):e7839. PubMed ID: 19915707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered epigenetic regulation of homeobox genes in human oral squamous cell carcinoma cells.
    Marcinkiewicz KM; Gudas LJ
    Exp Cell Res; 2014 Jan; 320(1):128-43. PubMed ID: 24076275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAF(V600E) Mutation and BRAF Pseudogene.
    Lin JD; Fu SS; Chen JY; Lee CH; Chau WK; Cheng CW; Wang YH; Lin YF; Fang WF; Tang KT
    Thyroid; 2016 May; 26(5):691-704. PubMed ID: 26914762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
    Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
    Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
    Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
    Duquette M; Sadow PM; Husain A; Sims JN; Antonello ZA; Fischer AH; Song C; Castellanos-Rizaldos E; Makrigiorgos GM; Kurebayashi J; Nose V; Van Hummelen P; Bronson RT; Vinco M; Giordano TJ; Dias-Santagata D; Pandolfi PP; Nucera C
    Oncotarget; 2015 Dec; 6(40):42445-67. PubMed ID: 26636651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic genes regulated by the BRAFV600E signaling are associated with alterations in the methylation and expression of tumor suppressor genes and patient survival in melanoma.
    Liu D; Liu X; Xing M
    Biochem Biophys Res Commun; 2012 Aug; 425(1):45-50. PubMed ID: 22820187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
    Packer LM; East P; Reis-Filho JS; Marais R
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):785-98. PubMed ID: 19682280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells.
    Wu Z; Huang M; Gong Y; Lin C; Guo W
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):355-361. PubMed ID: 29534162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells.
    Neri F; Zippo A; Krepelova A; Cherubini A; Rocchigiani M; Oliviero S
    Mol Cell Biol; 2012 Feb; 32(4):840-51. PubMed ID: 22184065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.